AI assistant
Sending…
PALISADE BIO, INC. — Director's Dealing 2021
Sep 22, 2021
35274_dirs_2021-09-22_c2b2be38-d0c4-4fe9-93bc-663ee4339350.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PALISADE BIO, INC. (PALI)
CIK: 0001357459
Period of Report: 2021-09-21
Reporting Person: Finley John David (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-21 | Common Stock | P | 2000 | $2.44 | Acquired | 14396 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 26322 | Indirect |
Footnotes
F1: The Reporting Person is the managing member of FCW Investments LLC and has sole investment and voting power over the securities held by this entity.
More from PALISADE BIO, INC.
Registration Form
2026
May 12
Interim / Quarterly Report
2026
May 12
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 11